Pharming Group to participate in March investor conference

Core Insights - Pharming Group N.V. will participate in the 37th Annual Roth Conference in Dana Point, California, from March 16-18, 2025, with a fireside chat scheduled for March 17 at 01:30 PM PT [1] - The company is focused on developing and commercializing innovative therapies for patients with rare and life-threatening diseases [3] Company Overview - Pharming Group N.V. is a global biopharmaceutical company headquartered in Leiden, the Netherlands, with a presence in over 30 markets across North America, Europe, the Middle East, Africa, and Asia-Pacific [3] - The company specializes in protein replacement therapies and precision medicines, including small molecules and biologics [3]